JF
OKUR

Jump Financial’s OnKure Therapeutics OKUR Stock Holding History

Jump Financial’s Portfolio OKUR Stock Details OKUR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93K Buy
+20,400
New +$87.5K ﹤0.01% 1908
2024
Q1 		– Sell
-2,532
Closed -$40.5K – 2378
2023
Q4 		$40.5K Buy
+2,532
New +$158K ﹤0.01% 1715

Other funds holding OKUR

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return
SG
StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jump Financial's OKUR Position: Q2 2026 in Review

Jump Financial opened a new position in OnKure Therapeutics (OKUR) in Q2 2026: 20,400 shares worth $93K. The stake represents ﹤0.01% of the portfolio and ranks #1908 among its holdings. This is a return to the name: Jump Financial previously reported a position in OKUR as recently as Q4 2023.

Jump Financial first reported a position in OKUR in Q4 2023 and has held it in 2 quarters since. 75 funds tracked by Wall St. Rank hold OKUR as of Q2 2026.

  • Jump Financial held 20,400 shares of OnKure Therapeutics worth $93K as of Q2 2026.
  • OnKure Therapeutics was a new Jump Financial position in Q2 2026.
  • OnKure Therapeutics made up ﹤0.01% of Jump Financial's portfolio in Q2 2026, its #1908 holding.
  • Jump Financial first reported a position in OnKure Therapeutics in Q4 2023 and has held it in 2 quarters since.
  • 75 funds tracked by Wall St. Rank held OnKure Therapeutics as of Q2 2026.

Based on Jump Financial's 13F filing for Q2 2026, filed 13 Aug 2026.